Q3 EPS Estimate for SBC Medical Group Decreased by Analyst

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

SBC Medical Group Holdings Incorporated (NASDAQ:SBC - Free Report) - Analysts at Sidoti Csr cut their Q3 2025 earnings estimates for SBC Medical Group in a research report issued on Monday, August 18th. Sidoti Csr analyst A. Shah now expects that the company will post earnings per share of $0.10 for the quarter, down from their prior forecast of $0.13. The consensus estimate for SBC Medical Group's current full-year earnings is $5.02 per share. Sidoti Csr also issued estimates for SBC Medical Group's Q4 2025 earnings at $0.11 EPS, Q1 2026 earnings at $0.11 EPS, Q2 2026 earnings at $0.13 EPS, Q3 2026 earnings at $0.13 EPS, Q4 2026 earnings at $0.14 EPS and FY2026 earnings at $0.50 EPS.

SBC Medical Group (NASDAQ:SBC - Get Free Report) last released its quarterly earnings results on Wednesday, August 13th. The company reported $0.02 EPS for the quarter, missing analysts' consensus estimates of $0.14 by ($0.12). SBC Medical Group had a net margin of 17.71% and a return on equity of 20.76%. The firm had revenue of $43.36 million during the quarter, compared to the consensus estimate of $44.71 million.

Separately, Wall Street Zen lowered shares of SBC Medical Group from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 16th.

SBC Medical Group Stock Performance

Shares of NASDAQ:SBC traded up $0.06 during trading on Tuesday, reaching $4.29. The stock had a trading volume of 43,474 shares, compared to its average volume of 44,629. SBC Medical Group has a 52 week low of $2.62 and a 52 week high of $19.50. The firm has a market capitalization of $445.65 million, a price-to-earnings ratio of 13.41 and a beta of 1.27. The company has a quick ratio of 3.95, a current ratio of 3.98 and a debt-to-equity ratio of 0.03. The stock has a fifty day simple moving average of $4.59 and a two-hundred day simple moving average of $4.19.

Hedge Funds Weigh In On SBC Medical Group

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Geode Capital Management LLC acquired a new stake in SBC Medical Group during the second quarter worth $455,000. SBI Securities Co. Ltd. boosted its stake in SBC Medical Group by 227.3% during the second quarter. SBI Securities Co. Ltd. now owns 54,177 shares of the company's stock worth $251,000 after buying an additional 37,623 shares in the last quarter. New York State Common Retirement Fund acquired a new stake in SBC Medical Group during the second quarter worth $104,000. Finally, XTX Topco Ltd acquired a new stake in SBC Medical Group during the second quarter worth $64,000. Institutional investors own 60.82% of the company's stock.

SBC Medical Group Company Profile

SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.